Physician profile
Julia D Moon
NPI 1265705750
$749.15
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $353 · 2022: $246 · 2023: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $150.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $213.59 | 2021-2023 | |
| Novo Nordisk INC | $166.20 | 2021-2023 | Wegovy |
| Organon LLC | $48.77 | 2021-2023 | Nexplanon |
| Myovant Sciences INC. | $48.49 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $46.19 | 2021 | |
| Currax Pharmaceuticals LLC | $41.29 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $41.06 | 2023 | Myfembree |
| Pfizer INC. | $36.24 | 2022-2023 | |
| Evofem Biosciences, INC. | $29.08 | 2021 | |
| Amgen INC. | $24.67 | 2021 | |
| Mayne Pharma Commercial LLC | $22.90 | 2022 | |
| Shield Therapeutics INC | $15.44 | 2023 | Accrufer |
| Merck Sharp & Dohme LLC | $15.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.